CODX Earnings Date & History
Co-Diagnostics Inc (NASDAQ NMS - GLOBAL MARKET) earnings schedule, consensus estimates and reported results for the last eight quarters.
Last updated Aug 19, 2026 at 7:33 PM ET
Co-Diagnostics Inc
Health Care
- Next earnings date
- Wednesday, November 11, 2026
- Reporting session
- Time TBD
- EPS estimate
- $-2.91
- Revenue estimate
- $175,440
CODX earnings history
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| Thursday, May 14, 2026 | Q1 2026 | $-3.83 | $-4.06 | -6.1% | $145,950 |
| Tuesday, March 31, 2026 | Q4 2025 | $-3.67 | $-3.64 | +0.9% | $264,000 |
| Thursday, November 13, 2025 | Q3 2025 | $-4.90 | $-4.80 | +2.0% | $145,000 |
| Thursday, August 14, 2025 | Q2 2025 | $-18.97 | $-6.90 | +63.6% | $163,000 |
What the market is watching in CODX's next report
- The full Earnings Read for this company: focus areas, peer read-through and prior-reaction context.
- Ticker Read combines trend, relative strength and catalysts in one research view.
- Scanners, Impact Radar and the members-only Weekly Watchlist are included.
Get the week's earnings by email
One free email each week: the reports that matter, when they land, and what the market is watching.
Frequently asked questions
- When is the next CODX earnings date?
- Co-Diagnostics Inc is scheduled to report on Wednesday, November 11, 2026 (Time TBD). Dates can change until the company confirms them.
- Does CODX report before or after the market?
- The next report is scheduled time tbd.
- What EPS is expected for CODX?
- Consensus EPS for the upcoming quarter is $-2.91, on revenue of $175,440.
Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.
CODX earnings discussion
Anyone can read. Any free Hyper Stocks account can join in.
Create a free account to join the discussion. Reading is open to everyone — commenting is free, no subscription needed.
Loading discussion…
Member comments are opinions from individual users, not Hyper Stocks research, and are never personalised investment advice.